Aurora physician receives Hind Rattan Award for MS research

Today the NRI Welfare Society of India recognized Bhupendra Khatri, M.D., of Aurora St. Luke's Medical Center with its prestigious Hind Rattan Award.

Dr. Khatri was selected for his extensive contribution to the field of multiple sclerosis and for his work as medical director of the Regional Multiple Sclerosis Center at Aurora St. Luke's Medical Center.

The Hind Rattan is given annually to about 30 people from India who have made significant contributions elsewhere in the world.

"I'm honored to receive this recognition," says Dr. Khatri. "Having multiple sclerosis can be devastating, which is why I have dedicated my career to finding a cure."

The Regional Multiple Sclerosis Center is one of the largest of its kind in the nation and offers comprehensive, individualized care for multiple sclerosis patients.

Dr. Khatri is involved in multiple clinical trials to find more effective treatments for multiple sclerosis. His accomplishments include research showing the long-term benefits of plasma exchange for treating multiple sclerosis. In addition, his research on the drug Tysabri has been published in Neurology, an American Academy of Neurology journal.

The National Multiple Sclerosis Society estimates 400,000 people in the United States have the disease. In Wisconsin, one in 500 people have multiple sclerosis, while in states like Texas it impacts only one in 10,000.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine